跳至主要内容
临床试验/NCT04509336
NCT04509336终止不适用

Comparison of the Efficacy and Safety of Orphenadrine Versus Baclofen in Treatment of Muscle Cramps in Cirrhotic Patients

Mansoura University1 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2020年8月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
终止
入组人数
5
试验地点
1
主要终点
the difference in the number of muscle cramps between the orphenadrine and baclofen groups at the end of treatment

研究概览

简要总结

Muscle cramps are commonly affects patients with cirrhosis. It adversely influences the quality of life of cirrhotic patients. Treatment of muscle cramps still challenging owing to the diversity of the responsible pathophysiological mechanisms.The effectiveness of baclofen and orphenadrine in controlling muscle cramps in cirrhotic patients has been presented in recent randomised controlled clinical trials;however, the comparative efficacy and safety between these two therapeutic options has not been previously investigated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-70 years
  • Cirrhotic patients complaining of frequent muscle cramps (>3 per week) for at least a month

排除标准

  • Patients with allergy to study drugs
  • Renal impairment
  • Peripheral vascular disease
  • Peripheral neuropathy
  • Prostatic enlargement
  • Pregnancy and lactation
  • Patients taking calcium channel blockers, and conjugated estrogens
  • Patients taking vitamin E, taurine, carnitine, narcotic pain medications, muscle relaxants, nonsteroidal anti-inflammatory drugs, or antispastic agents during and for 2 weeks following the study
  • Patients with alcoholic cirrhosis

研究组 & 干预措施

orphenadrine group

Experimental

orphenadrine

干预措施: Orphenadrine (Drug)

Baclofen group

Active Comparator

Baclofen

干预措施: Baclofen (Drug)

结局指标

主要结局

the difference in the number of muscle cramps between the orphenadrine and baclofen groups at the end of treatment

时间窗: 12 weeks

Questionnaire

次要结局

  • The difference in severity of cramps between orphenadrine and baclofen groups at the end of treatment(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Noha Mansour

Lecturer of clinical pharmacy, pharmacy practice department

Mansoura University

研究点 (1)

Loading locations...

相似试验